Lupin Pharmaceuticals Inc. recalls Cefdinir for Oral Suspension USP
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Defective container: lack of seal integrity.
- Products
-
- Cefdinir for Oral Suspension USP
- Company
- Lupin Pharmaceuticals Inc.
- Where it was sold
-
USA Nationwide
Nationwide
- Units affected
- 51,006 bottles
- About this recall
- Cefdinir for Oral Suspension USP, 250 mg/5 mL, packaged in a 60 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202, Manufactured by: Lupin Limited, Mandideep, 462 046 India, NDC 68180-723-04